日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dynamic ctDNA tracking stratifies relapse risk for triple negative breast cancer patients receiving neoadjuvant chemotherapy

动态ctDNA追踪可对接受新辅助化疗的三阴性乳腺癌患者的复发风险进行分层

Li, Shunying; Li, Yudong; Wei, Wei; Gong, Chang; Wang, Ting; Li, Guangxin; Yao, Feng; Ou, Jiang-Hua; Xu, Yan; Wu, Wei; Jin, Liang; Rao, Nanyan; Nie, Yan; Yu, Fengyan; Jia, Weijuan; Li, Xing-Rui; Zhang, Jun; Yang, Hua-Wei; Yang, Yaping; Wu, Mengzi; Li, Qin; Li, Fang; Gong, Yuhua; Yi, Xin; Liu, Qiang

STT3-mediated aberrant N-glycosylation of CD24 inhibits paclitaxel sensitivity in triple-negative breast cancer.

STT3 介导的 CD24 异常 N-糖基化抑制三阴性乳腺癌对紫杉醇的敏感性

Wang Jun, Zhang Hui-Min, Zhu Guan-Hua, Zhao Li-Li, Shi Ji, Dai Zhou-Tong, Li Jia-Peng, Li Xing-Rui, Sun Fan, Wu Yuan, Chen Shao-Yong, Li Han-Ning, Liao Xing-Hua, Xiang Yuan

lncRNA IGF2-AS regulates miR-500a-3p/PPP4R1/p-VEGFR2 signalling pathway to promote thyroid carcinoma progression and tubulogenesis

lncRNA IGF2-AS通过调控miR-500a-3p/PPP4R1/p-VEGFR2信号通路促进甲状腺癌进展和肾小管形成。

Xiang, Yuan; Zong, Qi-Bei; Liu, Hui; Li, Han-Ning; Wu, Qi-Fang; Dai, Zhou-Tong; Huang, You; Shen, Chao; Li, Le-Wei; Li, Xing-Rui; Liao, Xing-Hua

The role of lncRNA SNHG14 in gastric cancer: enhancing tumor cell proliferation and migration, and mechanisms of CDH2 expression.

lncRNA SNHG14 在胃癌中的作用:增强肿瘤细胞增殖和迁移,以及 CDH2 表达机制

Dai Zhou-Tong, Wu Yong-Lin, Xu Tao, Li Xing-Rui, Ji Teng

Exosomal HMGA2 protein from EBV-positive NPC cells destroys vascular endothelial barriers and induces endothelial-to-mesenchymal transition to promote metastasis

EBV 阳性鼻咽癌细胞外泌体 HMGA2 蛋白破坏血管内皮屏障并诱导内皮-间质转化以促进转移

Deng-Ke Li #, Xing-Rui Chen #, Li-Na Wang #, Jia-Hong Wang, Ji-Ke Li, Zi-Ying Zhou, Xin Li, Lin-Bo Cai, Shui-Sheng Zhong, Jing-Jing Zhang, Yu-Mei Zeng, Qian-Bing Zhang, Xiao-Yan Fu, Xiao-Ming Lyu, Min-Ying Li, Zhong-Xi Huang, Kai-Tai Yao

Circular RNA dehydrodolichyl diphosphate synthase facilitated triple-negative breast cancer progression via miR-362-3p/DDX5 axis

环状 RNA 脱氢表雄酮二磷酸合酶通过 miR-362-3p/DDX5 轴促进三阴性乳腺癌进展

Suping Cui, Yong Zhang, Li Xing, Rui Li, Yingshi Piao, Honggang Liu

S100A1 is a Potential Biomarker for Papillary Thyroid Carcinoma Diagnosis and Prognosis

S100A1 是甲状腺乳头状癌诊断和预后的潜在生物标志物

Ge Wang, Han-Ning Li, Xiao-Qing Cui, Tao Xu, Meng-Lu Dong, Shu-Yu Li, Xing-Rui Li

A multicenter, prospective study to observe the initial management of patients with differentiated thyroid cancer in China (DTCC study)

一项多中心前瞻性研究,旨在观察中国分化型甲状腺癌患者的初始治疗(DTCC 研究)

Ming, Jie; Zhu, Jing-Qiang; Zhang, Hao; Sun, Hui; Wang, Jun; Cheng, Ruo-Chuan; Xie, Lei; Li, Xing-Rui; Tian, Wen; Huang, Tao

Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high-level immune infiltration status

乳腺癌中 FREM1 表达升高提示预后良好及免疫浸润状态高

Han-Ning Li, Xing-Rui Li, Zheng-Tao Lv, Miao-Miao Cai, Ge Wang, Zhi-Fang Yang

ZW10 interacting kinetochore protein may serve as a prognostic biomarker for human breast cancer: An integrated bioinformatics analysis

ZW10相互作用的着丝粒蛋白可能作为人类乳腺癌的预后生物标志物:一项综合生物信息学分析

Li, Han-Ning; Zheng, Wei-Hong; Du, Ya-Ying; Wang, Ge; Dong, Meng-Lu; Yang, Zhi-Fang; Li, Xing-Rui